Position in PHVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,109,156
+$591,262 QoQ
Shares Held
89,912
+0.9% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 124 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. PHVS ranks #280 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PHVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,109,156 | 89,912 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,517,894 | 89,129 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,408,727 | 86,801 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,959,572 | 78,540 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $952,195 | 54,102 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $601,828 | 38,333 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $734,842 | 38,333 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $684,813 | 36,977 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $587,011 | 31,224 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $721,586 | 31,224 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $605,739 | 21,595 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $450,687 | 21,595 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $282,255 | 18,643 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $150,169 | 18,643 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $209,733 | 18,643 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $142,991 | 18,643 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $412,010 | 18,643 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $338,090 | 18,643 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $268,272 | 18,643 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $330,540 | 18,643 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $347,319 | 18,643 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $458,424 | 16,384 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||